跳至主要内容
临床试验/NCT05574140
NCT05574140招募中不适用

BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders (B-GLAD)

McGill University Health Centre/Research Institute of the McGill University Health Centre1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2022年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
84
试验地点
1
主要终点
Change in Signal Intensity

研究概览

简要总结

This study aims to view variations in MRI measurements of the heart and the brain in people with anxiety versus healthy volunteers. The MRI measurements used will be Oxygenation-Sensitive Cardiac MRI (OS-CMR), a recent type of MRI which is safe, fast, and non-invasive.

详细描述

The investigators will prospectively analyze OS-CMR data from patients with a generalized anxiety disorder from one site. The investigators will observe how an anxiety disorder affects the OS-CMR data. In a follow-up MRI scan, the investigators will look at the OS-CMR of a subgroup who have anxiety disorder and are also undertaking cognitive behavioural therapy to asses how and if this therapy affects the OS-CMR data.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patient population:
  • Confirmation of an anxiety disorder as identified by the PSWQ,
  • No known, current or history, of significant medical conditions that may affect or directly involve the neurological, cardiovascular or respiratory system (except anxiety and depression)
  • Non-smoker
  • Healthy Volunteers:
  • Age 18-55
  • No known, current or history, of significant medical conditions that may affect or directly involve the neurological, cardiovascular or respiratory system
  • Non-smoker

排除标准

  • General MRI contraindications: pacemakers, defibrillating wires, implanted defibrillators, intracranial aneurysm clips, metallic foreign bodies in the eyes, pregnancy
  • History of significant neurological disease or illness that is not anxiety (e.g. Dementia, stroke)
  • Hemodynamically unstable conditions
  • Significant or uncontrolled arrhythmias
  • Severe pulmonary disease
  • Recent (<90 days) myocardial infarction
  • Recent (<90 days) surgery or coronary intervention
  • Consumption of caffeine (caffeinated beverages, coffee, tea, cocoa, chocolate) within 12h of the exam
  • Use of benzodiazepines or other short-acting anxiety medications (<1 day)

结局指标

主要结局

Change in Signal Intensity

时间窗: Baseline

Change in signal intensity between the baseline signal intensity and the signal intensity at 30 seconds of breath hold

次要结局

未报告次要终点

研究者

发起方
McGill University Health Centre/Research Institute of the McGill University Health Centre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthias Friedrich

Principal Investigator

McGill University Health Centre/Research Institute of the McGill University Health Centre

研究点 (1)

Loading locations...

相似试验